San Francisco-based Plenful, a workflow-automation platform for pharmacy and healthcare operations, introduced it secured $17 million in Sequence A funding lower than a yr after launching with $9 million in funding.
TQ Ventures led the spherical, with participation from Mitchell Rales (cofounder and chairman of Danaher), Susa Ventures and current buyers.
WHAT IT DOES
Plenful gives pharmacy technicians a no-code AI-enabled automation instrument for guide and administrative workflow that features assist with doc knowledge entry for pharmacy income cycle, referral orders, auditing and financial savings identification.
The corporate will use the funds to scale advertising, gross sales and product improvement.
“We’re dedicated to remodeling pharmacy and healthcare operations by addressing the guide and administrative work that burdens the system, exacerbated by a major decline in graduating pharmacists, by modern AI automation options,” Pleasure Liu, founder and CEO of Plenful, advised MobiHealthNews in an electronic mail.
“By streamlining operations and assuaging labor shortages, we empower healthcare groups to prioritize affected person care. Plenful is devoted to enhancing pharmacy care supply and shaping a extra environment friendly future for healthcare.”
MARKET SNAPSHOT
One other firm that secured funding this week for its workflow automation platform is SamaCare.
The corporate helps suppliers get hold of prior authorization for specialty drug medicines, verify enrollment, and confirm advantages. It additionally makes use of knowledge analytics to offer pharmaceutical firms with info on bettering remedy entry.
SamaCare additionally secured $17 million in funding.
